Provided by Tiger Trade Technology Pte. Ltd.

Zhengye Biotechnology Holding Limited

1.63
-0.0200-1.21%
Post-market: 1.61-0.0200-1.23%17:58 EDT
Volume:54.63K
Turnover:88.42K
Market Cap:48.45M
PE:-7.73
High:1.68
Open:1.57
Low:1.57
Close:1.65
52wk High:13.08
52wk Low:0.6155
Shares:29.73M
Float Shares:4.42M
Volume Ratio:1.45
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2108
EPS(LYR):-0.2105
ROE:-25.17%
ROA:-9.48%
PB:1.30
PE(LYR):-7.74

Loading ...

NASDAQ Trade Halt Volatility Trading Pause at 09:55 Am

Reuters
·
Aug 07

Zhengye Biotechnology Regains NASDAQ Compliance with $1 Minimum Bid Price Rule

Reuters
·
Aug 06

Zhengye Biotechnology Holding Limited Regains Compliance with NASDAQ Bid Price Requirement

THOMSON REUTERS
·
Aug 06

Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement

GlobeNewswire
·
Aug 06

NASDAQ Trade Halt Volatility Trading Pause at 11:11 Am

Reuters
·
Aug 05

Top Premarket Gainers

MT Newswires Live
·
Jul 23

Top Premarket Decliners

MT Newswires Live
·
Jul 22

Top Midday Decliners

MT Newswires Live
·
Jul 22

U.S. Stocks on the Move-duke Robotics, Tesla, Hasbro

Reuters
·
Jul 22

NASDAQ Trade Halt Volatility Trading Pause at 10:16 Am

Reuters
·
Jul 21

Zhengye Biotechnology Holding Ltd trading halted, volatility trading pause

TIPRANKS
·
Jul 21

Zhengye Biotechnology issues statement in response to unusual trading activity

TIPRANKS
·
Jul 21

Zhengye Biotechnology Holding - not Aware of Material Non-public Information Explaining Trading Activity

THOMSON REUTERS
·
Jul 21

Zhengye Biotechnology Holding - in Contact with NASDAQ Regarding Trading Volume Increase

THOMSON REUTERS
·
Jul 21

Zhengye Biotech Says no Material Non-public Information Behind Unusual Share Trading Activity

Reuters
·
Jul 21

Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity

GlobeNewswire
·
Jul 21

Top Premarket Decliners

MT Newswires Live
·
Jul 21

NASDAQ Trade Halt Volatility Trading Pause at 09:33 Am

Reuters
·
Jul 20

Zhengye Biotechnology Says Director Jiang Ping Files Initial Beneficial Ownership Statement

Reuters
·
Jun 25

Zhengye Biotechnology Receives Nasdaq Letter for Minimum Bid Price Deficiency

MT Newswires Live
·
Jun 05